Study Group Efficacy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Study Group Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Study Group Efficacy Today - Breaking & Trending Today

Teva Pharmaceutical Industries Limited: United Kingdom first to grant licence for Teva's ophthalmology biosimilar Ongavia (ranibizumab)?

Published: May 17, 2022

MHRA today granted a licence for Ongavia (ranibizumab), a biosimilar to Lucentis*, for the treatment of (wet) age-related macular degeneration (AMD) and several other eye diseases, such as diabetic

Source: finanznachrichten.de

Related Topics:

United KingdomFrankg HolzPiotr OleksyFederico RicciJoachim KieferRichard DaniellPeterk KaiserSteffen Schmitz ValckenbergJohn LoweUnited Kingdom Medicines Healthcare Regulatory AgencyPolpharma Biologics GroupStudy Group EfficacyGenentech IncFormycon GroupExperimental Eye ResearchTeva Pharmaceutical Industries LtdPharmaceutical Industries LtdExecutive Vice PresidentTeva Europe CommercialPharmaceutical IndustriesGroup EfficacyNeovascular Age Related Macular DegenerationBritish JournalPrivate Securities Litigation Reform ActQuarterly Report